Difference between classical and non classical migraine..refer to Harrison textbook of medicine .

Reading File
Now let me search Harrison's for migraine content.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I found the Harrison's migraine section. Let me read the main migraine block in detail.
Reading File
Reading File
Let me now read the specific section on migraine headache features and the aura/classification content more carefully.
Reading File
Reading File
Now let me look for the detailed paragraph content about migraine with and without aura - the key clinical difference section.
Finding Sources
Reading File
Now let me get the diagnostic criteria table and aura description.
Finding Sources
Reading File
Now let me get the diagnostic criteria tables (Table 441-3) which should contain the formal criteria for migraine with and without aura.
Finding Sources
I have enough information from Harrison's. Now let me also fetch the brain pathways image and search for a visual of migraine aura.
Searching Images

migraine with aura visual scotoma scintillating

This sequence of three historical illustrations, labeled Figure 1 through Figure 3, depicts the temporal and spatial progression of a visual migraine aura (fortification spectra). Each figure presents a circular visual field with a central white fixation crosshair against a black background. The images demonstrate the characteristic 'march' of the aura from a central point toward the periphery. In Figure 1, a small, luminous, yellow-gold zig-zagged arc appears near the fixation point. In Figure 2, the disturbance has expanded into a larger crescent shape with a distinct crenellated or 'fortress-wall' border, accompanied by a trailing area of relative scotoma or blurred vision. Figure 3 illustrates the advanced stage, where the jagged, iridescent arc has migrated to the superior periphery of the visual field, significantly increasing in scale. These illustrations by James Mackenzie serve as a classic clinical representation of the neurological phenomenon of cortical spreading depression as perceived by a patient, highlighting the hallmark characteristics of teichopsia: jagged morphology, peripheral expansion, and associated visual field deficit.

This sequence of three historical illustrations, labeled Figure 1 through Figure 3, depicts the temporal and spatial progression of a visual migraine aura (fortification spectra). Each figure presents a circular visual field with a central white fixation crosshair against a black background. The images demonstrate the characteristic 'march' of the aura from a central point toward the periphery. In Figure 1, a small, luminous, yellow-gold zig-zagged arc appears near the fixation point. In Figure 2, the disturbance has expanded into a larger crescent shape with a distinct crenellated or 'fortress-wall' border, accompanied by a trailing area of relative scotoma or blurred vision. Figure 3 illustrates the advanced stage, where the jagged, iridescent arc has migrated to the superior periphery of the visual field, significantly increasing in scale. These illustrations by James Mackenzie serve as a classic clinical representation of the neurological phenomenon of cortical spreading depression as perceived by a patient, highlighting the hallmark characteristics of teichopsia: jagged morphology, peripheral expansion, and associated visual field deficit.

This historical medical illustration, titled 'Stages of Teichopsia' (1870), is a landmark clinical diagram representing the progression of a migraine aura across the visual field. The image depicts nine chronological stages (numbered 1-9) of a visual disturbance known as a scintillation scotoma or 'fortification spectrum'. The sequence begins with a small, central point of light and evolves into an expanding, crescentic arc. The figures are characterized by their jagged, crenellated edges, resembling the bastions of a fortified town, which Hubert Airy termed 'teichopsia'. These edges feature a prismatic or polychromatic effect, with alternating segments of red, green, blue, and yellow against a dark background, illustrating the 'shimmering' or 'boiling' nature of the aura. The diagram is an important record in the history of neurology and ophthalmology, providing a subjective yet scientifically detailed mapping of transient hemiopsia and the physiological manifestation of cortical spreading depression as perceived by a patient. This content is relevant for studying the clinical presentation of migraine with aura and the history of diagnostic visualization in neurology.

This historical medical illustration, titled 'Stages of Teichopsia' (1870), is a landmark clinical diagram representing the progression of a migraine aura across the visual field. The image depicts nine chronological stages (numbered 1-9) of a visual disturbance known as a scintillation scotoma or 'fortification spectrum'. The sequence begins with a small, central point of light and evolves into an expanding, crescentic arc. The figures are characterized by their jagged, crenellated edges, resembling the bastions of a fortified town, which Hubert Airy termed 'teichopsia'. These edges feature a prismatic or polychromatic effect, with alternating segments of red, green, blue, and yellow against a dark background, illustrating the 'shimmering' or 'boiling' nature of the aura. The diagram is an important record in the history of neurology and ophthalmology, providing a subjective yet scientifically detailed mapping of transient hemiopsia and the physiological manifestation of cortical spreading depression as perceived by a patient. This content is relevant for studying the clinical presentation of migraine with aura and the history of diagnostic visualization in neurology.

This diagnostic image displays resting-state functional MRI (rs-fMRI) seed-to-voxel connectivity analysis results for patients with migraine with aura (MWA). The visual is divided into two sections, A and B, each showing three orthogonal brain views (coronal, sagittal, and axial) and an accompanying bar graph. Section A illustrates increased functional connectivity between the right antero-dorsal insula (ROI 1 R) and a posterior cluster colored in red/orange. Section B illustrates increased functional connectivity between the left antero-dorsal insula (ROI 1 L) and a similar cluster colored in blue. Blue crosshairs in both sections localize the primary cluster to the cerebellar vermis (Vermis VI/VII) and the lingual gyrus. The bar graphs compare 'Effect Sizes' between Healthy Controls (HC) and Migraine with Aura (MWA) patients, indicating significantly higher connectivity in the MWA group (p-FDR < 0.001). Anatomical landmarks visible include the cerebral cortex, corpus callosum, brainstem, and cerebellar hemispheres. This image is used to demonstrate neuro-pathophysiological differences in functional brain networks associated with migraine disorders.

This diagnostic image displays resting-state functional MRI (rs-fMRI) seed-to-voxel connectivity analysis results for patients with migraine with aura (MWA). The visual is divided into two sections, A and B, each showing three orthogonal brain views (coronal, sagittal, and axial) and an accompanying bar graph. Section A illustrates increased functional connectivity between the right antero-dorsal insula (ROI 1 R) and a posterior cluster colored in red/orange. Section B illustrates increased functional connectivity between the left antero-dorsal insula (ROI 1 L) and a similar cluster colored in blue. Blue crosshairs in both sections localize the primary cluster to the cerebellar vermis (Vermis VI/VII) and the lingual gyrus. The bar graphs compare 'Effect Sizes' between Healthy Controls (HC) and Migraine with Aura (MWA) patients, indicating significantly higher connectivity in the MWA group (p-FDR < 0.001). Anatomical landmarks visible include the cerebral cortex, corpus callosum, brainstem, and cerebellar hemispheres. This image is used to demonstrate neuro-pathophysiological differences in functional brain networks associated with migraine disorders.

I now have comprehensive information from Harrison's 22nd edition to give a thorough, well-cited answer. Let me compile it.

Classical vs. Non-Classical Migraine - Harrison's Principles of Internal Medicine, 22nd Edition (2025)

Terminology note: The older terms "classical migraine" and "non-classical (common) migraine" have been replaced in modern classification. The International Classification of Headache Disorders-III (ICHD-III), as reproduced in Harrison's Table 441-1, now uses:
  • Classical migraine = Migraine with aura (ICHD 1.2)
  • Non-classical (common) migraine = Migraine without aura (ICHD 1.1)

Overview

Harrison's describes migraine as "a recurring syndrome of headache associated with other symptoms of neurologic dysfunction in varying admixtures." It afflicts ~15% of women and 6% of men. A migraine attack has three to four phases: premonitory (prodrome), aura (in ~20-25% of patients), headache phase, and postdrome.

ICHD Classification (Harrison's Table 441-1)

CodeType
1.1Migraine without aura (non-classical)
1.2Migraine with aura (classical)
1.2.1Migraine with typical aura
1.2.1.1Typical aura with headache
1.2.1.2Typical aura without headache (acephalgic migraine)
1.2.2Migraine with brainstem aura
1.2.3Hemiplegic migraine
1.2.4Retinal migraine
1.3Chronic migraine

Key Differences at a Glance

FeatureClassical Migraine (with aura)Non-Classical Migraine (without aura)
Old termClassical migraineCommon migraine
Prevalence~20-25% of migraineurs~75-80% of migraineurs (majority)
AuraPresent - focal neurologic symptoms preceding headacheAbsent
Aura typeVisual (most common: scintillating scotoma, zigzag/fortification spectra), sensory, speechNone
Aura durationTypically 20-30 min, by definition reversible and <60 minN/A
Onset of headacheFollows or overlaps with auraNo aura precedes it
Headache characterThrobbing/pulsating, often unilateralThrobbing/pulsating, often unilateral
Associated featuresNausea, vomiting, photophobia, phonophobia, allodyniaSame
Stroke riskElevated (especially in women using combined OCP)Lower
OCP contraindicationYes - estrogen-containing contraceptives are contraindicatedNo absolute contraindication
Triptan timingTriptans NOT effective during aura; must be given after aura ends and headache beginsTriptans effective at headache onset
GeneticsIon channel mutations implicated (FHM genes: CACNA1A, ATP1A2, SCN1A)Polygenic susceptibility

The Aura - Detailed (Harrison's)

Harrison's states the aura consists of "visual disturbances with flashing lights or zigzag lines moving across the visual field or other neurologic symptoms" and is reported in only 20-25% of patients. It must be distinguished from "visual snow," a pan-field television-static-like disturbance that is a separate entity.
The classic visual aura is a scintillating scotoma - a crescent-shaped, shimmering arc with fortification (jagged) borders that starts near the center of vision and expands toward the periphery over ~20 minutes:
Fortification spectra - migraine visual aura progression
Historical illustration of scintillation scotoma (teichopsia) progression - the hallmark aura of classical migraine.
Other aura types include:
  • Sensory aura - paresthesias (pins and needles) spreading in a characteristic march
  • Motor aura - weakness (hemiplegic migraine - a special subtype)
  • Speech/language aura - dysphasia
  • Brainstem aura - dysarthria, vertigo, tinnitus, diplopia (replaced older term "basilar artery migraine")

Phases of a Migraine Attack (both types share these, except aura)

As described in Harrison's Table 441-2:
  1. Premonitory/Prodromal phase (hours to days before headache):
    • Neck discomfort, cognitive impairment ("brain fog"), mood change, fatigue, yawning/sleepiness, polyuria/polydipsia, food cravings
  2. Aura (classical migraine only):
    • Neurologic disturbance, typically scintillating scotoma, lasting 20-30 min
  3. Headache phase:
    • Pain (typically unilateral, throbbing), nausea/vomiting, photophobia, phonophobia, osmophobia, allodynia, vertigo
  4. Postdrome:
    • Tiredness, weariness, concentration impairment - lasting hours to up to a day

Pathophysiology (both types share the same core mechanism)

Harrison's explains that both forms share the trigeminovascular pathway as the key pain generator. Brainstem/hypothalamic dysfunction leads to trigeminal nucleus activation, releasing CGRP and PACAP at vascular terminals. The difference in classical migraine is the additional cortical spreading depression (CSD) - a slowly propagating wave of neuronal depolarization followed by suppression that underlies the aura.
Genetic studies of Familial Hemiplegic Migraine (FHM) - the extreme end of classical migraine - identified:
  • FHM1: CACNA1A (Ca2.1 P/Q-type calcium channel)
  • FHM2: ATP1A2 (Na+/K+ ATPase)
  • FHM3: SCN1A (neuronal voltage-gated sodium channel)
These all suggest that altered membrane excitability predisposes to the aura phenomenon.

Clinical Implications

  1. Contraception: Harrison's explicitly states that migraine with aura is a contraindication to estrogen-containing contraceptives (combined OCP, patch, ring), due to increased stroke risk. Progestin-only methods are safe.
  2. Triptan use: "Triptans are generally not effective in migraine with aura unless given after the aura is completed and the headache initiated." - Harrison's 22E. In migraine without aura, triptans can be given at headache onset.
  3. Acephalgic migraine (aura without headache, ICHD 1.2.1.2): A patient can have the full aura of classical migraine with little or no head pain. This is particularly relevant in older patients and must be differentiated from TIA.
  4. Stroke association (migrainous infarction): A complication listed under ICHD 1.4.3 - occurs almost exclusively in migraine with aura.

Source: Harrison's Principles of Internal Medicine, 22nd Edition (2025, McGraw Hill Medical), Chapter 441 - Headache, pp. 3505-3515.

Okay, so basically I need to know the pathogenesis of migraine. Refer to, uh, Harrison Textbook of Medicine. Yes.

Reading File
From the previous session I already know the Harrison's migraine block is at /textbooks/9781265977061/9781265977061_block49.md, with the pathogenesis section starting around line 544. Let me read it comprehensively now.
Reading File
Searching Images

migraine pathogenesis trigeminovascular brainstem cortical spreading depression

This pathophysiology diagram illustrates the neurobiological mechanisms of migraine with aura, focusing on Cortical Spreading Depression (CSD) and trigeminovascular activation. A sagittal view of the human brain highlights the cortex, thalamus, hypothalamus, cerebellum, and brainstem. In the posterior cortex, CSD is represented by a red-shaded area characterized by increased extracellular potassium (K+) and excitatory glutamate (Glu). The diagram traces neurochemical signaling pathways, including serotonin (5-HT) from the Dorsal Raphe Nucleus (DRN) and norepinephrine (NA) from the Locus Coeruleus (LC) projecting to the cortex. Pain processing involves the Trigeminal Nucleus Caudalis (TNC), Periaqueductal Gray (PAG), and thalamus. The 'Headache' phase is linked to meningeal stimulation and peripheral neurogenic inflammation, shown via a detailed inset of a trigeminal neuron releasing Calcitonin Gene-Related Peptide (CGRP) onto vascular receptors. Pharmacological modulation is indicated at the bottom, showing where beta-blockers and antidepressants interfere with CSD and trigeminal hypersensitivity. This visual resource is designed for advanced medical education regarding the pathogenesis of primary headache disorders.

This pathophysiology diagram illustrates the neurobiological mechanisms of migraine with aura, focusing on Cortical Spreading Depression (CSD) and trigeminovascular activation. A sagittal view of the human brain highlights the cortex, thalamus, hypothalamus, cerebellum, and brainstem. In the posterior cortex, CSD is represented by a red-shaded area characterized by increased extracellular potassium (K+) and excitatory glutamate (Glu). The diagram traces neurochemical signaling pathways, including serotonin (5-HT) from the Dorsal Raphe Nucleus (DRN) and norepinephrine (NA) from the Locus Coeruleus (LC) projecting to the cortex. Pain processing involves the Trigeminal Nucleus Caudalis (TNC), Periaqueductal Gray (PAG), and thalamus. The 'Headache' phase is linked to meningeal stimulation and peripheral neurogenic inflammation, shown via a detailed inset of a trigeminal neuron releasing Calcitonin Gene-Related Peptide (CGRP) onto vascular receptors. Pharmacological modulation is indicated at the bottom, showing where beta-blockers and antidepressants interfere with CSD and trigeminal hypersensitivity. This visual resource is designed for advanced medical education regarding the pathogenesis of primary headache disorders.

This pathophysiology diagram illustrates the central mechanisms of migraine, overlaid on a sagittal view of the human brain. The illustration highlights the interplay between several key neuroanatomical structures and processes. A central text box indicates 'Hypothalamic activation' leading to 'premonitory symptoms', with arrows showing its influence on the 'Spinal trigeminal nucleus' in the brainstem. Cortical spreading depression, associated with 'aura', is depicted as a large arrow targeting the same spinal trigeminal nucleus. The diagram outlines the involvement of the trigeminal nerve system, showing bidirectional activity: activation of the spinal trigeminal nucleus leads to 'Neurogenic inflammation at the trigeminal ganglion and terminal' (represented by a starburst graphic), while 'Neurotransmitter' release is shown signaling back from the brainstem to the peripheral trigeminal structures. This diagram serves as an educational tool for medical students and clinicians to understand the trigeminovascular system's role in migraine pathogenesis, specifically how hypothalamic and cortical triggers converge on the brainstem and peripheral nerve terminals.

This pathophysiology diagram illustrates the central mechanisms of migraine, overlaid on a sagittal view of the human brain. The illustration highlights the interplay between several key neuroanatomical structures and processes. A central text box indicates 'Hypothalamic activation' leading to 'premonitory symptoms', with arrows showing its influence on the 'Spinal trigeminal nucleus' in the brainstem. Cortical spreading depression, associated with 'aura', is depicted as a large arrow targeting the same spinal trigeminal nucleus. The diagram outlines the involvement of the trigeminal nerve system, showing bidirectional activity: activation of the spinal trigeminal nucleus leads to 'Neurogenic inflammation at the trigeminal ganglion and terminal' (represented by a starburst graphic), while 'Neurotransmitter' release is shown signaling back from the brainstem to the peripheral trigeminal structures. This diagram serves as an educational tool for medical students and clinicians to understand the trigeminovascular system's role in migraine pathogenesis, specifically how hypothalamic and cortical triggers converge on the brainstem and peripheral nerve terminals.

This pathophysiology diagram illustrates the neurological pathways involved in migraine pain generation within a schematic human brain. The process begins externally with 'Triggers' leading to Cortical Spreading Depression (CSD), depicted as a curved arrow over the cerebral cortex. An oval labeled 'TVS Activation' (Trigemino-Vascular System) is situated in the frontal lobe, influenced by 'Gene mutations.' A dotted signaling pathway descends from the TVS to the 'TG' (Trigeminal Ganglion) and subsequently to the 'TNC' (Trigeminal Nucleus Caudalis) located in the brainstem. The TNC receives modulatory input from 'BN' (brainstem nuclei), such as the periaqueductal gray or locus coeruleus. Finally, a dotted arrow ascends from the brainstem toward the somatosensory areas of the cortex, labeled 'PAIN,' representing the perception of a migraine attack. This diagram serves as an educational tool for understanding the trigeminovascular system's role and the transition from cortical excitation to sensory pain perception in pediatric and adult migraine pathology.

This pathophysiology diagram illustrates the neurological pathways involved in migraine pain generation within a schematic human brain. The process begins externally with 'Triggers' leading to Cortical Spreading Depression (CSD), depicted as a curved arrow over the cerebral cortex. An oval labeled 'TVS Activation' (Trigemino-Vascular System) is situated in the frontal lobe, influenced by 'Gene mutations.' A dotted signaling pathway descends from the TVS to the 'TG' (Trigeminal Ganglion) and subsequently to the 'TNC' (Trigeminal Nucleus Caudalis) located in the brainstem. The TNC receives modulatory input from 'BN' (brainstem nuclei), such as the periaqueductal gray or locus coeruleus. Finally, a dotted arrow ascends from the brainstem toward the somatosensory areas of the cortex, labeled 'PAIN,' representing the perception of a migraine attack. This diagram serves as an educational tool for understanding the trigeminovascular system's role and the transition from cortical excitation to sensory pain perception in pediatric and adult migraine pathology.

This pathophysiology diagram illustrates the progression of cortical spreading depression (CSD) across the human brain, specifically in the context of migraine pathogenesis. The illustration shows a lateral view of the cerebral cortex, with labeled regions including the frontal, parietal, temporal, and occipital lobes, as well as the cerebellum. The CSD originates as a localized starburst icon in the occipital lobe. Gray arrows depict its anterior propagation through the parieto-occipital regions, moving across the cortical surface. The progression is shown to respect certain anatomical boundaries, marked by solid and dashed lines representing the medial and lateral sulci. In the frontal lobe, the culmination of this wave is represented by a shaded gray area labeled 'Aura,' bordered by a ring of small stars. A lightning bolt icon is positioned adjacent to the aura, signifying the neurological discharge or electrical disturbances associated with visual or sensory migraine symptoms. This diagram serves as a pedagogical tool to explain how spreading oligemia and neuronal depolarization correlate with the clinical transition from migraine triggers to symptomatic aura.

This pathophysiology diagram illustrates the progression of cortical spreading depression (CSD) across the human brain, specifically in the context of migraine pathogenesis. The illustration shows a lateral view of the cerebral cortex, with labeled regions including the frontal, parietal, temporal, and occipital lobes, as well as the cerebellum. The CSD originates as a localized starburst icon in the occipital lobe. Gray arrows depict its anterior propagation through the parieto-occipital regions, moving across the cortical surface. The progression is shown to respect certain anatomical boundaries, marked by solid and dashed lines representing the medial and lateral sulci. In the frontal lobe, the culmination of this wave is represented by a shaded gray area labeled 'Aura,' bordered by a ring of small stars. A lightning bolt icon is positioned adjacent to the aura, signifying the neurological discharge or electrical disturbances associated with visual or sensory migraine symptoms. This diagram serves as a pedagogical tool to explain how spreading oligemia and neuronal depolarization correlate with the clinical transition from migraine triggers to symptomatic aura.

Good, now let me read further to capture the dopamine, genetics, and cortical spreading depression sections.
Reading File
Loading Image
I now have everything needed from Harrison's for a comprehensive pathogenesis answer. Let me compile it.

Pathogenesis of Migraine

Harrison's Principles of Internal Medicine, 22nd Edition (2025)


Core Concept

Harrison's opens the pathogenesis section with this key statement:
"The sensory sensitivity that is characteristic of migraine is probably due to dysfunction of monoaminergic and other sensory control systems located in the brainstem and hypothalamus."
Migraine is fundamentally a disorder of sensory processing - the brain of a migraineur does not habituate normally to sensory stimuli, and this sets the stage for the entire attack cascade.

The Trigeminovascular System - The Central Pathway

The primary pain pathway in migraine is the trigeminovascular system (TVS):
Brainstem pathways modulating sensory input in migraine - Harrison's Figure 441-1
Harrison's Fig. 441-1: The trigeminovascular pain pathway. Nociceptive input from meningeal vessels travels via the trigeminal ganglion to the TCC, ascends via the quintothalamic tract to the thalamus and cortex. Modulation comes from the dorsal raphe nucleus, locus coeruleus, and nucleus raphe magnus.
Step-by-step pathway (per Harrison's):
  1. Peripheral activation: Nociceptive afferents from the meningeal blood vessels (dura mater) are activated. These run with the trigeminal nerve (V1) to the trigeminal ganglion.
  2. First-order neuron → TCC: These fibers synapse in the trigeminocervical complex (TCC) - specifically the trigeminal nucleus caudalis in the brainstem/upper cervical cord.
  3. Neuropeptide release: Activation of trigeminal nucleus cells causes release of vasoactive neuropeptides at vascular terminals and within the nucleus:
    • CGRP (Calcitonin Gene-Related Peptide) - the most important
    • PACAP (Pituitary Adenylate Cyclase Activating Polypeptide)
    • These cause neurogenic inflammation and vasodilation
  4. Second-order neurons → Thalamus: Second-order neurons cross the midline and project via the quintothalamic tract to the ventrobasal and posterior nuclei of the thalamus for further processing.
  5. Higher projections: From TCC and thalamus, there are also projections to:
    • Periaqueductal gray (PAG) and hypothalamus - these send back descending antinociceptive modulation (which is dysfunctional in migraineurs)
    • Locus coeruleus (pons) and parabrachial nucleus (pons)
    • Rostroventromedial medulla
The failure of these descending inhibitory systems to suppress the trigeminal pain signal is a key mechanism in why the headache persists and escalates.

Role of CGRP (and Why It Matters Clinically)

CGRP is the dominant neuropeptide in migraine pathogenesis. Evidence from Harrison's:
  • CGRP receptor antagonists (gepants) - atoregepant, rimegepant, ubrogepant, zavegepant - are effective in both acute and preventive treatment of migraine
  • Four monoclonal antibodies targeting CGRP or its receptor (erenumab, fremanezumab, galcanezumab, eptinezumab) are proven effective for prevention
  • A PACAP monoclonal antibody showed efficacy in a phase 2 preventive study
This pharmacologic validation confirms CGRP/trigeminovascular activation as the core mechanism.

Role of Serotonin (5-HT)

Harrison's cites extensive pharmacologic evidence for serotonin's role:
  • Methysergide (5-HT antagonist) - one of the earliest migraine preventives, demonstrating 5-HT involvement since the 1950s
  • At least 14 different 5-HT receptors exist in humans
  • Triptans are potent agonists at 5-HT₁B and 5-HT₁D receptors (and some at 5-HT₁F):
    • Arrest nociceptive nerve signaling in the trigeminovascular system at the trigeminal nucleus caudalis and trigeminal sensory thalamus
    • Also promote cranial vasoconstriction
  • Ditans (lasmiditan) are selective 5-HT₁F receptor agonists - they act only at neural targets (no vasoconstriction), confirming a purely neuronal component to the mechanism

Role of Dopamine

Harrison's highlights a distinct dopaminergic component:
  • Many premonitory symptoms (yawning, nausea, vomiting, hypotension) can be induced by dopaminergic stimulation
  • Migraineurs show dopamine receptor hypersensitivity - dopaminergic agonists at sub-threshold doses trigger a full migraine attack in migraineurs but not in normal individuals
  • Dopamine receptor antagonists (e.g., metoclopramide, prochlorperazine) are effective acute treatments, especially parenterally
  • Hypothalamic activation (anterior region) is visible on functional imaging during the premonitory phase - this region is rich in dopaminergic circuits and likely underlies the premonitory symptoms

Genetics - Ion Channel Dysfunction

Harrison's explicitly links migraine pathogenesis to membrane excitability disorders, studied through Familial Hemiplegic Migraine (FHM):
GeneProteinFHM Type% of FHM cases
CACNA1ACa₂.₁ (P/Q-type) voltage-gated calcium channelFHM 1~50%
ATP1A2Na⁺/K⁺ ATPaseFHM 2~20%
SCN1ANeuronal voltage-gated sodium channelFHM 3Remainder
Key insight: All three mutations involve ion channels - this strongly suggests that altered membrane excitability (neuronal hyperexcitability) underlies the propensity to develop aura (cortical spreading depression) and migraine attacks.

Cortical Spreading Depression (CSD) - Basis of the Aura

While Harrison's does not dedicate a separate subheading to CSD in this chapter, it describes the aura as "visual disturbances with flashing lights or zigzag lines moving across the visual field or other neurologic symptoms" and links it directly to the ion channel mutations above. CSD is a slowly propagating wave of neuronal and glial depolarization followed by suppression that spreads at ~3 mm/min across the cortex - it underlies the typical march of visual symptoms in classical migraine.
Migraine pathogenesis - CSD and trigeminovascular activation
Schematic showing CSD (cortical spreading depression) in the posterior cortex releasing K⁺ and glutamate, activating trigeminal pathways via the TNC, with modulation from the DRN (serotonin) and LC (noradrenaline).

Functional Neuroimaging Evidence

Harrison's references PET imaging data (Fig. 441-2) showing:
  • Hypothalamic activation - in the premonitory phase, before any pain
  • Dorsal midbrain and dorsolateral pontine activation - present during the migraine attack
  • Dorsolateral pontine area (locus coeruleus) - activation persists during the attack and even in chronic migraine
  • The lateralization of pontine changes correlates with the side of headache in hemicranial migraine - this is compelling evidence that the brainstem generator is real, not an epiphenomenon

Triggers - The Final Common Pathway

Harrison's lists triggers that precipitate attacks in genetically predisposed individuals, acting by lowering the threshold for trigeminovascular activation:
  • Altered sleep patterns
  • Hunger / skipped meals
  • "Let-down" from stress (post-stress relaxation)
  • Physical exertion
  • Barometric pressure changes / stormy weather
  • Hormonal fluctuations (menstrual cycle, perimenopause)
  • Alcohol and nitrates (chemical vasodilators that activate CGRP release)
  • Sensory overload (bright lights, loud sounds)
Harrison's notes that some "apparent triggers" - such as light sensitivity - may actually be early manifestations of the premonitory phase rather than true triggers; i.e., the brain has already entered the attack cascade before the patient notices the light sensitivity.

Summary Diagram of Pathogenesis

GENETIC PREDISPOSITION (ion channel mutations → neuronal hyperexcitability)
            ↓
TRIGGER EXPOSURE
            ↓
HYPOTHALAMIC ACTIVATION (premonitory phase - dopaminergic)
            ↓
CORTICAL SPREADING DEPRESSION (aura - in 20-25% of patients)
            ↓
TRIGEMINOVASCULAR ACTIVATION
  Meningeal afferents → Trigeminal ganglion → TCC (trigeminal nucleus caudalis)
            ↓
NEUROPEPTIDE RELEASE (CGRP, PACAP) → Neurogenic inflammation + vasodilation
            ↓
SECOND-ORDER NEURONS cross midline → Thalamus (quintothalamic tract)
            ↓
FAILURE OF DESCENDING INHIBITION (PAG, locus coeruleus, raphe nuclei)
            ↓
CORTICAL PAIN PERCEPTION + SENSITIZATION (allodynia, photophobia, phonophobia)

Source: Harrison's Principles of Internal Medicine, 22nd Edition (2025, McGraw Hill Medical), Chapter 441 - Headache, pp. 3505-3508.
This is a shared conversation. Sign in to Orris to start your own chat.